
Pioneering generative biology to create breakthrough medicines
Generate Biomedicines develops a generative biology platform focused on de novo protein and antibody therapeutics. It maintains an integrated computational and experimental engine. Compared with Nabla Bio, Generate has disclosed larger financing and broader modality ambitions while sharing the core goal of designing functional proteins directly from models with internal testing.
Free